LISUNAR Canadian Trademark Information
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of pulmonary hypertension, multiple sclerosis, asthma, allergic rhinitis, cystic fibrosis, psoriasis, antiobesity, hypnotic sedatives, anxiolytics, pharmaceutical preparations for the treatment of insomnia, eating disorders and cognitive disorders.Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of pulmonary hypertension, multiple sclerosis, asthma, allergic rhinitis, cystic fibrosis, psoriasis, antiobesity, hypnotic sedatives, anxiolytics, pharmaceutical preparations for the treatment of insomnia, eating disorders and cognitive disorders. Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of pulmonary hypertension, multiple sclerosis, asthma, allergic rhinitis, cystic fibrosis, psoriasis, antiobesity, hypnotic sedatives, anxiolytics, pharmaceutical preparations for the treatment of insomnia, eating disorders and cognitive disorders.
Perfect for these industries
Words that describe this mark
pharmaceutical preparations pharmaceutical preparations treatment pulmonary hypertension multiple sclerosis asthma allergic rhinitis cystic fibrosis psoriasis antiobesity hypnotic sedatives anxiolytics pharmaceutical preparations treatment insomnia eating disorders
Abandonment Notice!
On Wednesday, January 30, 2013,
status on the LISUNAR
trademark changed to Application withdrawn.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Thursday, May 8, 2008, a canadian trademark registration was filed for
LISUNAR by Actelion Pharmaceuticals Ltd. *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1394784.
The current status of this trademark filing is Application withdrawn.
The LISUNAR
trademark is filed in the description of
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of pulmonary hypertension, multiple sclerosis, asthma, allergic rhinitis, cystic fibrosis, psoriasis, antiobesity, hypnotic sedatives, anxiolytics, pharmaceutical preparations for the treatment of insomnia, eating disorders and cognitive disorders.
,
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of pulmonary hypertension, multiple sclerosis, asthma, allergic rhinitis, cystic fibrosis, psoriasis, antiobesity, hypnotic sedatives, anxiolytics, pharmaceutical preparations for the treatment of insomnia, eating disorders and cognitive disorders.
,
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of pulmonary hypertension, multiple sclerosis, asthma, allergic rhinitis, cystic fibrosis, psoriasis, antiobesity, hypnotic sedatives, anxiolytics, pharmaceutical preparations for the treatment of insomnia, eating disorders and cognitive disorders.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information